PL3517958T3 - Środki i sposoby określania ryzyka wystąpienia cukrzycy typu 1 przez biomarkery białka w surowicy - Google Patents

Środki i sposoby określania ryzyka wystąpienia cukrzycy typu 1 przez biomarkery białka w surowicy

Info

Publication number
PL3517958T3
PL3517958T3 PL19160490T PL19160490T PL3517958T3 PL 3517958 T3 PL3517958 T3 PL 3517958T3 PL 19160490 T PL19160490 T PL 19160490T PL 19160490 T PL19160490 T PL 19160490T PL 3517958 T3 PL3517958 T3 PL 3517958T3
Authority
PL
Poland
Prior art keywords
diabetes
methods
type
serum protein
protein biomarkers
Prior art date
Application number
PL19160490T
Other languages
English (en)
Inventor
Robert MOULDER
Santosh BHOSALE
David GOODLETT
Harri LÄHDESMÄKI
Olli Simell
Riitta Lahesmaa
Original Assignee
Turun Yliopisto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Turun Yliopisto filed Critical Turun Yliopisto
Publication of PL3517958T3 publication Critical patent/PL3517958T3/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4713Plasma globulins, lactoglobulin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4716Complement proteins, e.g. anaphylatoxin, C3a, C5a
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/76Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/775Apolipopeptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2560/00Chemical aspects of mass spectrometric analysis of biological material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/042Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/50Determining the risk of developing a disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/60Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PL19160490T 2014-06-18 2015-06-18 Środki i sposoby określania ryzyka wystąpienia cukrzycy typu 1 przez biomarkery białka w surowicy PL3517958T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FI20140186 2014-06-18
PCT/FI2015/050448 WO2015193552A2 (en) 2014-06-18 2015-06-18 Means and methods for determining risk of type-1 diabetes by serum protein biomarkers
EP15738959.4A EP3158337B1 (en) 2014-06-18 2015-06-18 Methods for determining risk of type-1 diabetes by serum protein biomarkers
EP19160490.9A EP3517958B1 (en) 2014-06-18 2015-06-18 Means and methods for determining risk of type-1 diabetes by serum protein biomarkers

Publications (1)

Publication Number Publication Date
PL3517958T3 true PL3517958T3 (pl) 2021-04-19

Family

ID=53673964

Family Applications (2)

Application Number Title Priority Date Filing Date
PL15738959T PL3158337T3 (pl) 2014-06-18 2015-06-18 Sposoby określania i ryzyka cukrzycy typu 1 przez biomarkery białkowe w surowicy
PL19160490T PL3517958T3 (pl) 2014-06-18 2015-06-18 Środki i sposoby określania ryzyka wystąpienia cukrzycy typu 1 przez biomarkery białka w surowicy

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL15738959T PL3158337T3 (pl) 2014-06-18 2015-06-18 Sposoby określania i ryzyka cukrzycy typu 1 przez biomarkery białkowe w surowicy

Country Status (7)

Country Link
US (2) US10877034B2 (pl)
EP (2) EP3158337B1 (pl)
DK (2) DK3517958T3 (pl)
ES (2) ES2825573T3 (pl)
HU (1) HUE052117T2 (pl)
PL (2) PL3158337T3 (pl)
WO (1) WO2015193552A2 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114113624B (zh) * 2020-08-28 2024-08-16 香港城市大学深圳研究院 利用免疫球蛋白关联蛋白质组开发疾病标志物的方法及装置
KR102748577B1 (ko) * 2022-07-19 2025-01-06 가천대학교 산학협력단 바이오마커 enpp7의 당뇨병의 진단 및 치료 용도

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1840573A1 (en) * 2006-03-27 2007-10-03 Institut Pasteur Secreted proteins as early markers and drug targets for autoimmunity, tumorigenesis and infections
WO2010141469A2 (en) * 2009-06-01 2010-12-09 Case Western Reserve University Protein biomarkers and therapeutic targets for autoimmune and alloimmune diseases
US20120177660A1 (en) * 2011-01-06 2012-07-12 Georgia Health Sciences University Research Institute, Inc. Biomarkers and therapeutic targets for type 1 diabetes
WO2013106851A2 (en) * 2012-01-13 2013-07-18 Eastern Virginia Medical School Syncollin, pancreatic triacylglycerol lipase, and other biomarkers for diabetes
WO2014015217A1 (en) * 2012-07-19 2014-01-23 Vertex Pharmaceuticals Incorporated Biomarkers for hcv infected patients

Also Published As

Publication number Publication date
EP3517958A1 (en) 2019-07-31
ES2825573T3 (es) 2021-05-17
EP3517958B1 (en) 2020-08-12
US20170160276A1 (en) 2017-06-08
US12007391B2 (en) 2024-06-11
EP3158337B1 (en) 2019-03-06
PL3158337T3 (pl) 2019-08-30
DK3158337T3 (da) 2019-05-13
US20210080458A1 (en) 2021-03-18
EP3158337A2 (en) 2017-04-26
DK3517958T3 (da) 2020-10-12
HUE052117T2 (hu) 2021-04-28
WO2015193552A3 (en) 2016-03-24
US10877034B2 (en) 2020-12-29
ES2728669T3 (es) 2019-10-28
WO2015193552A2 (en) 2015-12-23

Similar Documents

Publication Publication Date Title
SG11201607796TA (en) Nanopore-based analysis of protein characteristics
PL3138489T3 (pl) Zestaw do określania stężenia analitu
SG11201706367WA (en) Systems and methods for assessing biological samples
SG11201606193RA (en) Biomolecule analysis kit and biomolecule analysis method
ZA201606987B (en) Methods and compositions for detecting misfolded proteins
TWD174576S (zh) 分析儀之部分
EP3217249A4 (en) Method and structure for determining inter-system global clock
EP3123174A4 (en) Means and methods for determination of quality of blood samples based on metabolite panel
IL249395A0 (en) Quantitative analysis of transgenic proteins
EP3158330A4 (en) Apparatuses and methods for determining analyte charge
EP3190416A4 (en) Biomarker for predicting sensitivity to protein kinase inhibitor and use thereof
SG11201610431WA (en) Methods and reagents for purification of proteins
EP3185004A4 (en) Method for measuring viscosity of protein solution
IL254765A0 (en) A method for the monomerization of recombinant antibody molecules
IL251945A0 (en) A method for displaying proteins on the surface of cells
GB201412156D0 (en) Analyte concentration measurement
PT3322985T (pt) Dispositivo para detetar proteínas mal dobradas e seus métodos de uso
IL246642A0 (en) Materials and methods for quantifying pld-1 protein levels
GB201505198D0 (en) Determining glucose content of a sample
EP3129781A4 (en) Protein biomarkers for immune assessment and prediction of transplant rejection
PL3160645T3 (pl) Urządzenie i sposób oznaczania analitu we krwi
GB201402347D0 (en) Fixative solution for materials or samples of biological origin
DK3144679T3 (da) Prøveanalyseindretning
PL3517958T3 (pl) Środki i sposoby określania ryzyka wystąpienia cukrzycy typu 1 przez biomarkery białka w surowicy
IL247996A0 (en) A method for detecting changes in proteins